Big Rock Partners Acquisition Corp (BRPA) Stock News

NASDAQ:BRPA -

24.25

-3.27 (-11.88%)

Last: 5/24/2021, 8:08:27 PM

23.7

-0.55 (-2.27%)

After Hours: 5/24/2021, 8:08:27 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

BRPA Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Kaskela Law LLC - Mentions: NRXP

News Image

SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of NRx Pharmaceuticals, Inc. and Encourages Long-Term NRXP / BRPA Shareholders to Contact the Firm

4 years ago - By: Benzinga - Mentions: PRVB EPIX HZNP KNSA ...

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal

4 years ago - By: NRx Pharmaceuticals

NRx Pharmaceuticals, Inc. Commences Trading on Nasdaq as NRXP, Following Merger Between NeuroRx, Inc. and Big Rock Partners Acquisition Corp (Nasdaq:BRPA)

4 years ago - By: Benzinga - Mentions: AMC CGA TDUP VRTV ...

52 Biggest Movers From Yesterday

4 years ago - By: Big Rock Partners Acquisition Corp.

Big Rock Partners Acquisition Corp. Announces Effectiveness of Registration Statement; Confirms Annual Meeting Date of May 24, 2021 to Approve Proposed Merger with NeuroRx

4 years ago - By: NeuroRx

NeuroRx and Georgian Ministry of Health Agree to Initiate Expanded Access Program of ZYESAMI (aviptadil acetate) for COVID-19 Respiratory Failure in Georgia

4 years ago - By: NeuroRx

Dr. Anthony Fauci Confirms ZYESAMI Phase 3 Trial with Remdesivir at Press Briefing by White House COVID-19 Response Team

4 years ago - By: NeuroRx

NeuroRx Responds to Issues Raised by Relief Therapeutics Regarding ZYESAMI development

4 years ago - By: Big Rock Partners Acquisition Corp.

Big Rock Partners Acquisition Corp. Clarifies Procedure for Stockholder Conversions and Urges Stockholders To Vote "For" Extension Amendment Proposal

4 years ago - By: InvestorPlace

What Will the Stock Market Do Today? 3 Big Stories to Watch.

4 years ago - By: NeuroRx

NeuroRx Announces Completion of Data Analysis in Phase 2b/3 Clinical Trial of ZYESAMI™ for the Treatment of COVID-19 Respiratory Failure

4 years ago - By: Big Rock Partners Acquisition Corp.

Neurorx, Inc. and Big Rock Partners Acquisition Corp. Announce Committed $10 Million Pipe to Support Proposed Business Combination

4 years ago - By: NeuroRx; TFF Pharmaceuticals - Mentions: TFFP

NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration